Signos

Signos is a personalized platform that empowers people to make informed decisions about their health and weight loss journey based on real-time data from their own personal continuous glucose monitor (CGM). By combining the power of AI and the Dexcom G7 sensor, Signos offers continuous glucose monitoring and personalized insights to help people take control of their blood sugar levels.

Signos is designed to help people optimize their metabolism and achieve their health goals by monitoring and managing blood sugar levels. The company says everyone's metabolic response to food is different, and Signos offers personalized support through in-app nutritionists and predictive glucose data. Users get alerts in real-time when glucose levels are spiking, along with personalized advice on how to bring levels back down.

Features include:

• Real-time blood sugar and trend data: See glucose levels at all times.
• In-app nutritionist support: Get expert advice on meal planning and healthy eating.
• Predictive glucose data: See how meals will affect glucose levels.
• Exercise and activity recommendations: Make informed decisions about physical activity.
• Stable energy levels: Get consistent energy throughout the day.
• Insight alerts: Get alerts when glucose levels are spiking.

The Signos program includes:

• Real-time blood sugar and trends
• Personalized blood sugar targets
• In-app nutritionist support
• Meal impact predictions
• Workout and activity tracking
• Fasting and meal-timing tips
• Sleep, hydration, and stress monitoring
• Weekly reports to track progress

The Dexcom G7 sensor is the foundation of Signos, providing high accuracy, a 60% smaller size and no fingerstick or scanning. Users will experience a comfortable and unobtrusive wearable.

Signos is for people who want to lose weight and improve their health by managing glucose. The platform combines AI insights with continuous glucose monitoring to offer a holistic approach to healthier living. Pricing starts at $449 per month, which includes access to the Signos app, continuous glucose monitors and digital telehealth assessments. Insurance coverage is not available at this time, but HSA/FSA funds may be eligible for reimbursement.

Published on July 4, 2024